Aquestive Therapeutics Ownership 2024 | Who Owns Aquestive Therapeutics Now?
Institutional Ownership
57.59%
Insider Ownership
5.03%
Retail Ownership
37.39%
Institutional Holders
98.00
Aquestive Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 13.33% | 100.00% | 9,810,958 | - | - | 25,508,491 | Jun 30, 2024 |
| VR ADVISER, LLC | 7.55% | 0.92% | 5,555,555 | - | - | 14,444,443 | Jun 30, 2024 |
| BLACKROCK INC. | 7.41% | 0.00% | 5,454,743 | 4,109,867 | 305.59% | 14,182,331 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.74% | 0.00% | 4,227,672 | 985,101 | 30.38% | 10,991,947 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 3.88% | 0.00% | 2,854,242 | 634,242 | 28.57% | 7,421,029 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14% | 0.00% | 1,576,972 | 1,038,516 | 192.87% | 4,100,583 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 1.55% | 0.82% | 1,140,000 | 265,000 | 30.29% | 2,964,000 | Jun 30, 2024 |
| STATE STREET CORP | 1.34% | 0.00% | 984,057 | 802,420 | 441.77% | 2,558,548,000 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | 1.20% | 0.01% | 880,485 | 538,625 | 157.56% | 2,289,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.07% | 0.00% | 785,023 | 785,023 | 100.00% | 2,041,060 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.98% | 0.00% | 718,100 | -131,113 | -15.44% | 1,867,060 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.96% | 0.34% | 705,184 | 92,235 | 15.05% | 1,833,478 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.82% | 0.01% | 600,959 | 367 | 0.06% | 1,562,493 | Jun 30, 2024 |
| MORGAN STANLEY | 0.76% | 0.00% | 555,986 | 463,064 | 498.34% | 1,445,564 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.72% | 0.33% | 530,000 | 30,000 | 6.00% | 1,378,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 0.00% | 496,200 | -879,600 | -63.93% | 1,290,120 | Jun 30, 2024 |
| BRACEBRIDGE CAPITAL, LLC | 0.58% | 0.20% | 428,571 | - | - | 1,114,285 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.54% | 0.00% | 397,482 | 7,600 | 1.95% | 1,033,453 | Jun 30, 2024 |
| LATASH INVESTMENTS, LLC | 0.33% | 0.51% | 243,134 | - | - | 632,148 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.33% | 0.34% | 242,712 | 174,624 | 256.47% | 631,051 | Jun 30, 2024 |
Aquestive Therapeutics's largest institutional shareholder is BRATTON CAPITAL MANAGEMENT, L.P., holding 13.33% of the company's total share outstanding, currently valued at $25.51M. The top 10 institutional shareholders own together 45.19% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 13.33% | 100.00% | 9,810,958 | - | - | 25,508,491 | Jun 30, 2024 |
| VR ADVISER, LLC | 7.55% | 0.92% | 5,555,555 | - | - | 14,444,443 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 1.55% | 0.82% | 1,140,000 | 265,000 | 30.29% | 2,964,000 | Jun 30, 2024 |
| LATASH INVESTMENTS, LLC | 0.33% | 0.51% | 243,134 | - | - | 632,148 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.96% | 0.34% | 705,184 | 92,235 | 15.05% | 1,833,478 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.33% | 0.34% | 242,712 | 174,624 | 256.47% | 631,051 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.72% | 0.33% | 530,000 | 30,000 | 6.00% | 1,378,000 | Jun 30, 2024 |
| BRACEBRIDGE CAPITAL, LLC | 0.58% | 0.20% | 428,571 | - | - | 1,114,285 | Jun 30, 2024 |
| CAHILL WEALTH MANAGEMENT, LLC | 0.16% | 0.18% | 118,561 | 32,348 | 37.52% | 308,259 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.33% | 0.08% | 242,371 | -6,132 | -2.47% | 630,165 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.10% | 0.03% | 72,177 | 72,177 | 100.00% | 187,660 | Jun 30, 2024 |
| PBMARES WEALTH MANAGEMENT LLC | 0.04% | 0.02% | 28,407 | 28,407 | 100.00% | 73,857 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.12% | 0.02% | 88,390 | 63,594 | 256.47% | 229,814 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.82% | 0.01% | 600,959 | 367 | 0.06% | 1,562,493 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 0.01% | 192,856 | - | - | 501,426 | Jun 30, 2024 |
| PFG INVESTMENTS, LLC | 0.08% | 0.01% | 59,000 | 11,000 | 22.92% | 153,400 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | 1.20% | 0.01% | 880,485 | 538,625 | 157.56% | 2,289,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.05% | 0.01% | 37,901 | -64,935 | -63.14% | 99,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.18% | 0.01% | 130,920 | 99,864 | 321.56% | 340,392 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.20% | 0.01% | 146,155 | 146,155 | 100.00% | 380,003 | Jun 30, 2024 |
The largest Aquestive Therapeutics shareholder by % of total assets is BRATTON CAPITAL MANAGEMENT, L.P.. The company owns 9.81M shares of Aquestive Therapeutics (AQST), representing 100.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 7.41% | 0.00% | 5,454,743 | 4,109,867 | 305.59% | 14,182,331 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14% | 0.00% | 1,576,972 | 1,038,516 | 192.87% | 4,100,583 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.74% | 0.00% | 4,227,672 | 985,101 | 30.38% | 10,991,947 | Jun 30, 2024 |
| STATE STREET CORP | 1.34% | 0.00% | 984,057 | 802,420 | 441.77% | 2,558,548,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.07% | 0.00% | 785,023 | 785,023 | 100.00% | 2,041,060 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 3.88% | 0.00% | 2,854,242 | 634,242 | 28.57% | 7,421,029 | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | 1.20% | 0.01% | 880,485 | 538,625 | 157.56% | 2,289,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.76% | 0.00% | 555,986 | 463,064 | 498.34% | 1,445,564 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 1.55% | 0.82% | 1,140,000 | 265,000 | 30.29% | 2,964,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.31% | 0.00% | 228,351 | 228,351 | 100.00% | 593,713 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.31% | 0.00% | 230,154 | 207,561 | 918.70% | 598,400 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.26% | 0.00% | 194,272 | 175,194 | 918.30% | 505,107 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.33% | 0.34% | 242,712 | 174,624 | 256.47% | 631,051 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.20% | 0.01% | 146,155 | 146,155 | 100.00% | 380,003 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.15% | 0.00% | 108,213 | 108,213 | 100.00% | 282,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.18% | 0.01% | 130,920 | 99,864 | 321.56% | 340,392 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.13% | 0.00% | 97,837 | 97,837 | 100.00% | 254,372 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.26% | 0.00% | 194,024 | 96,104 | 98.15% | 504,462,000 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.96% | 0.34% | 705,184 | 92,235 | 15.05% | 1,833,478 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.19% | 0.00% | 136,628 | 81,882 | 149.57% | 355,233 | Jun 30, 2024 |
As of Jun 30 2024, Aquestive Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 4.11M stocks of AQST, valued at $14.18M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -1,545,300 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 0.00% | 496,200 | -879,600 | -63.93% | 1,290,120 | Jun 30, 2024 |
| INVESCO LTD. | 0.12% | - | 89,041 | -808,471 | -90.08% | 231,506 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -702,941 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -665,000 | -100.00% | - | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -600,000 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -533,567 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -414,480 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.15% | 0.00% | 114,009 | -412,413 | -78.34% | 296,423 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.12% | 0.00% | 90,862 | -403,583 | -81.62% | 236,241 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -285,360 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.02% | 0.00% | 12,653 | -209,433 | -94.30% | 32,898 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.07% | 0.00% | 47,817 | -171,582 | -78.21% | 124,324 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.98% | 0.00% | 718,100 | -131,113 | -15.44% | 1,867,060 | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -108,244 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.01% | - | 10,188 | -85,025 | -89.30% | 26,489 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -81,000 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.02% | 0.00% | 18,225 | -71,775 | -79.75% | 47,385 | Jun 30, 2024 |
As of Jun 30 2024, Aquestive Therapeutics's biggest institutional seller is LAURION CAPITAL MANAGEMENT LP. The company sold -1.55M shares of AQST, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NUVEEN ASSET MANAGEMENT, LLC | 1.07% | 0.00% | 785,023 | 785,023 | 100.00% | 2,041,060 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.20% | 0.01% | 146,155 | 146,155 | 100.00% | 380,003 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.13% | 0.00% | 97,837 | 97,837 | 100.00% | 254,372 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.10% | 0.03% | 72,177 | 72,177 | 100.00% | 187,660 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.06% | - | 41,280 | 41,280 | 100.00% | 107,328 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 39,953 | 39,953 | 100.00% | 104,277 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 38,700 | 38,700 | 100.00% | 101,000 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.04% | 0.00% | 29,371 | 29,371 | 100.00% | 76,365 | Jun 30, 2024 |
| PBMARES WEALTH MANAGEMENT LLC | 0.04% | 0.02% | 28,407 | 28,407 | 100.00% | 73,857 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 25,841 | 25,841 | 100.00% | 67,187 | Jun 30, 2024 |
| BARCLAYS PLC | 0.04% | - | 25,770 | 25,770 | 100.00% | 67,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.03% | 0.00% | 21,928 | 21,928 | 100.00% | 57,000 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 19,380 | 19,380 | 100.00% | 50,388 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.02% | 0.00% | 15,870 | 15,870 | 100.00% | 41,000 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | 0.02% | 0.00% | 14,000 | 14,000 | 100.00% | 36,400 | Jun 30, 2024 |
| STATE OF WYOMING | 0.02% | 0.01% | 13,176 | 13,176 | 100.00% | 34,258 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.01% | - | 10,299 | 10,299 | 100.00% | 26,777 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 8,100 | 8,100 | 100.00% | 21,060 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 7,276 | 7,276 | 100.00% | 18,918 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 6,890 | 6,890 | 100.00% | 17,810 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 5,381 | 5,381 | 100.00% | 13,991 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | 0.00% | 3,000 | 3,000 | 100.00% | 7,800 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 2,569 | 2,569 | 100.00% | 7,000 | Jun 30, 2024 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 50 | 50 | 100.00% | 130 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | - | - | 16 | 16 | 100.00% | 42 | Jun 30, 2024 |
Aquestive Therapeutics's largest new institutional shareholder by number of shares is NUVEEN ASSET MANAGEMENT, LLC, purchased 785.02K shares, valued at $2.04M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -1,545,300 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -702,941 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -665,000 | -100.00% | - | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -600,000 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -533,567 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -414,480 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -285,360 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -108,244 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -81,000 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -62,747 | -100.00% | - | Jun 30, 2024 |
| EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -52,168 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -44,076 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -40,957 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -29,112 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -20,200 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -17,965 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -17,400 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -17,000 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -16,592 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -12,572 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -11,618 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -11,548 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -10,500 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -8,200 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -3,707 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -1,404 | -100.00% | - | Jun 30, 2024 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | - | - | - | -700 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -269 | -100.00% | - | Jun 30, 2024 |
Aquestive Therapeutics's largest sold out institutional shareholder by shares sold is LAURION CAPITAL MANAGEMENT LP, sold -1.55M shares, valued at -, as of undefined.
Aquestive Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 47,200 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 187,356 | - | - | Mar 28, 2024 |
| IndexIQ ETF Trust | 0.04% | 81,213 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,136,909 | 722,268 | 29.91% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 531,933 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 77,579 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 34,284 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,296 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 3,700 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 11,420 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 102,180 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 482,569 | 67,173 | 16.17% | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 5,107 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.00% | 8,417 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 38,200 | 17,658 | 85.96% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 55,778 | - | - | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 12,076 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,755 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,192 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 19,078 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,040 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 164 | - | - | Apr 30, 2021 |
| Meeder Funds | 0.00% | 1,276 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 871 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 11,906 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 536,958 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 183,799 | - | - | Mar 31, 2024 |
| 1290 Funds | 0.00% | 182,315 | 182,315 | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,196 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 11,340 | - | - | Mar 28, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 24,163 | - | - | Jan 31, 2024 |
| PGIM ETF TRUST | 0.00% | 4,539 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,700 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 194,485 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 3,884 | - | - | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 181 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 431 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 8,424 | 2,048 | 32.12% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 9,432 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 65,547 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,949 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 8,125 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,677 | - | - | Jan 31, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 16,480 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,487 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 4,458 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,030 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 177 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 800 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 16,200 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,149 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 89,982 | -1,052 | -1.16% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,501 | -478 | -6.85% | Mar 31, 2024 |
| MFS SERIES TRUST X | 0.00% | 42,006 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 994 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,508 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 8,668 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 8,071 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 3,537 | - | - | Mar 28, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,541 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,231 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 894 | 599 | 203.05% | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 3,222 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,170 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 18 | - | - | Jan 31, 2024 |
Aquestive Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 47.20K shares, compromising 0.09% of its total assets.
Aquestive Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 98 | -4.85% |
| 31 Mar, 24 | 103 | 68.85% |
| 31 Dec, 23 | 61 | 17.31% |
| 30 Sep, 23 | 52 | -8.77% |
| 30 Jun, 23 | 57 | 58.33% |
| 31 Mar, 23 | 36 | -5.26% |
| 31 Dec, 22 | 38 | -11.63% |
| 30 Sep, 22 | 43 | 2.38% |
| 30 Jun, 22 | 42 | -23.64% |
| 31 Mar, 22 | 55 | -3.51% |
| 31 Dec, 21 | 57 | 16.33% |
| 30 Sep, 21 | 49 | -16.95% |
| 30 Jun, 21 | 59 | -14.49% |
| 31 Mar, 21 | 69 | 1.47% |
| 31 Dec, 20 | 68 | 4.62% |
| 30 Sep, 20 | 65 | 4.84% |
| 30 Jun, 20 | 62 | 47.62% |
| 31 Mar, 20 | 42 | -26.32% |
| 31 Dec, 19 | 57 | 62.86% |
| 30 Sep, 19 | 35 | -10.26% |
| 30 Jun, 19 | 39 | -20.41% |
| 31 Mar, 19 | 49 | 36.11% |
| 31 Dec, 18 | 36 | -18.18% |
| 30 Sep, 18 | 44 | - |
As of 30 Jun 24, 98 institutions are holding Aquestive Therapeutics's shares, representing a decrease of -4.85% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 42,393,620 | 2.17% |
| 31 Mar, 24 | 41,494,848 | 74.43% |
| 31 Dec, 23 | 23,788,793 | 3.91% |
| 30 Sep, 23 | 22,893,946 | 20.01% |
| 30 Jun, 23 | 19,076,504 | 27.72% |
| 31 Mar, 23 | 14,936,246 | 0.08% |
| 31 Dec, 22 | 14,924,441 | -6.10% |
| 30 Sep, 22 | 15,894,336 | -4.99% |
| 30 Jun, 22 | 16,729,193 | 7.60% |
| 31 Mar, 22 | 15,547,762 | -3.79% |
| 31 Dec, 21 | 16,160,267 | 9.36% |
| 30 Sep, 21 | 14,777,626 | -5.33% |
| 30 Jun, 21 | 15,608,938 | -6.14% |
| 31 Mar, 21 | 16,630,648 | -13.11% |
| 31 Dec, 20 | 19,140,873 | -3.74% |
| 30 Sep, 20 | 19,884,663 | 7.41% |
| 30 Jun, 20 | 18,512,105 | 15.90% |
| 31 Mar, 20 | 15,971,960 | -8.51% |
| 31 Dec, 19 | 17,458,390 | 28.52% |
| 30 Sep, 19 | 13,583,801 | -6.42% |
| 30 Jun, 19 | 14,516,166 | 0.67% |
| 31 Mar, 19 | 14,419,459 | 0.34% |
| 31 Dec, 18 | 14,369,930 | -10.66% |
| 30 Sep, 18 | 16,085,187 | - |
Aquestive Therapeutics (AQST) has 42.39M shares outstanding as of 30 Jun 24, up 2.17% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 57.59% | 1.25% |
| 31 Mar, 24 | 67.74% | 5.01% |
| 31 Dec, 23 | 36.78% | 2.31% |
| 30 Sep, 23 | 39.92% | 3.39% |
| 30 Jun, 23 | 34.29% | 4.76% |
| 31 Mar, 23 | 26.85% | 2.86% |
| 31 Dec, 22 | 30.62% | 3.46% |
| 30 Sep, 22 | 29.75% | 2.20% |
| 30 Jun, 22 | 36.80% | 2.62% |
| 31 Mar, 22 | 37.50% | 2.34% |
| 31 Dec, 21 | 40.01% | 2.82% |
| 30 Sep, 21 | 37.67% | 2.12% |
| 30 Jun, 21 | 42.11% | 1.93% |
| 31 Mar, 21 | 46.76% | 1.45% |
| 31 Dec, 20 | 56.88% | 1.63% |
| 30 Sep, 20 | 59.15% | 1.95% |
| 30 Jun, 20 | 55.11% | 2.43% |
| 31 Mar, 20 | 47.58% | 1.00% |
| 31 Dec, 19 | 68.85% | 2.34% |
| 30 Sep, 19 | 54.27% | 1.61% |
| 30 Jun, 19 | 58.11% | 1.74% |
| 31 Mar, 19 | 57.76% | 1.74% |
| 31 Dec, 18 | 57.61% | 1.24% |
| 30 Sep, 18 | 68.02% | - |
As of 30 Jun 24, Aquestive Therapeutics is held by 57.59% institutional shareholders, representing a 1.25% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 59 | -20.27% |
| 31 Mar, 24 | 74 | 131.25% |
| 31 Dec, 23 | 32 | 68.42% |
| 30 Sep, 23 | 19 | -54.76% |
| 30 Jun, 23 | 42 | 180.00% |
| 31 Mar, 23 | 15 | 50.00% |
| 31 Dec, 22 | 10 | -41.18% |
| 30 Sep, 22 | 17 | 6.25% |
| 30 Jun, 22 | 16 | -27.27% |
| 31 Mar, 22 | 22 | -31.25% |
| 31 Dec, 21 | 32 | 77.78% |
| 30 Sep, 21 | 18 | -37.93% |
| 30 Jun, 21 | 29 | -6.45% |
| 31 Mar, 21 | 31 | - |
| 31 Dec, 20 | 31 | -18.42% |
| 30 Sep, 20 | 38 | -9.52% |
| 30 Jun, 20 | 42 | 55.56% |
| 31 Mar, 20 | 27 | -34.15% |
| 31 Dec, 19 | 41 | 156.25% |
| 30 Sep, 19 | 16 | 23.08% |
| 30 Jun, 19 | 13 | -60.61% |
| 31 Mar, 19 | 33 | 65.00% |
| 31 Dec, 18 | 20 | -54.55% |
| 30 Sep, 18 | 44 | - |
59 institutional shareholders have increased their position in AQST stock as of 30 Jun 24 compared to 74 in the previous quarter (a -20.27% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 23 | 64.29% |
| 31 Mar, 24 | 14 | 7.69% |
| 31 Dec, 23 | 13 | - |
| 30 Sep, 23 | 13 | 550.00% |
| 30 Jun, 23 | 2 | -71.43% |
| 31 Mar, 23 | 7 | -30.00% |
| 31 Dec, 22 | 10 | -16.67% |
| 30 Sep, 22 | 12 | - |
| 30 Jun, 22 | 12 | -36.84% |
| 31 Mar, 22 | 19 | 58.33% |
| 31 Dec, 21 | 12 | -25.00% |
| 30 Sep, 21 | 16 | -30.43% |
| 30 Jun, 21 | 23 | 4.55% |
| 31 Mar, 21 | 22 | - |
| 31 Dec, 20 | 22 | 29.41% |
| 30 Sep, 20 | 17 | 70.00% |
| 30 Jun, 20 | 10 | -9.09% |
| 31 Mar, 20 | 11 | -8.33% |
| 31 Dec, 19 | 12 | 9.09% |
| 30 Sep, 19 | 11 | -26.67% |
| 30 Jun, 19 | 15 | 66.67% |
| 31 Mar, 19 | 9 | - |
| 31 Dec, 18 | 9 | - |
| 30 Sep, 18 | - | - |
23 institutional shareholders have reduced their position in AQST stock as of 30 Jun 24 compared to 14 in the previous quarter (a 64.29% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 98 | -4.85% | 42,393,620 | 2.17% | 57.59% | 1.25% | 59 | -20.27% | 23 | 64.29% |
| 31 Mar, 24 | 103 | 68.85% | 41,494,848 | 74.43% | 67.74% | 5.01% | 74 | 131.25% | 14 | 7.69% |
| 31 Dec, 23 | 61 | 17.31% | 23,788,793 | 3.91% | 36.78% | 2.31% | 32 | 68.42% | 13 | - |
| 30 Sep, 23 | 52 | -8.77% | 22,893,946 | 20.01% | 39.92% | 3.39% | 19 | -54.76% | 13 | 550.00% |
| 30 Jun, 23 | 57 | 58.33% | 19,076,504 | 27.72% | 34.29% | 4.76% | 42 | 180.00% | 2 | -71.43% |
| 31 Mar, 23 | 36 | -5.26% | 14,936,246 | 0.08% | 26.85% | 2.86% | 15 | 50.00% | 7 | -30.00% |
| 31 Dec, 22 | 38 | -11.63% | 14,924,441 | -6.10% | 30.62% | 3.46% | 10 | -41.18% | 10 | -16.67% |
| 30 Sep, 22 | 43 | 2.38% | 15,894,336 | -4.99% | 29.75% | 2.20% | 17 | 6.25% | 12 | - |
| 30 Jun, 22 | 42 | -23.64% | 16,729,193 | 7.60% | 36.80% | 2.62% | 16 | -27.27% | 12 | -36.84% |
| 31 Mar, 22 | 55 | -3.51% | 15,547,762 | -3.79% | 37.50% | 2.34% | 22 | -31.25% | 19 | 58.33% |
| 31 Dec, 21 | 57 | 16.33% | 16,160,267 | 9.36% | 40.01% | 2.82% | 32 | 77.78% | 12 | -25.00% |
| 30 Sep, 21 | 49 | -16.95% | 14,777,626 | -5.33% | 37.67% | 2.12% | 18 | -37.93% | 16 | -30.43% |
| 30 Jun, 21 | 59 | -14.49% | 15,608,938 | -6.14% | 42.11% | 1.93% | 29 | -6.45% | 23 | 4.55% |
| 31 Mar, 21 | 69 | 1.47% | 16,630,648 | -13.11% | 46.76% | 1.45% | 31 | - | 22 | - |
| 31 Dec, 20 | 68 | 4.62% | 19,140,873 | -3.74% | 56.88% | 1.63% | 31 | -18.42% | 22 | 29.41% |
| 30 Sep, 20 | 65 | 4.84% | 19,884,663 | 7.41% | 59.15% | 1.95% | 38 | -9.52% | 17 | 70.00% |
| 30 Jun, 20 | 62 | 47.62% | 18,512,105 | 15.90% | 55.11% | 2.43% | 42 | 55.56% | 10 | -9.09% |
| 31 Mar, 20 | 42 | -26.32% | 15,971,960 | -8.51% | 47.58% | 1.00% | 27 | -34.15% | 11 | -8.33% |
| 31 Dec, 19 | 57 | 62.86% | 17,458,390 | 28.52% | 68.85% | 2.34% | 41 | 156.25% | 12 | 9.09% |
| 30 Sep, 19 | 35 | -10.26% | 13,583,801 | -6.42% | 54.27% | 1.61% | 16 | 23.08% | 11 | -26.67% |
| 30 Jun, 19 | 39 | -20.41% | 14,516,166 | 0.67% | 58.11% | 1.74% | 13 | -60.61% | 15 | 66.67% |
| 31 Mar, 19 | 49 | 36.11% | 14,419,459 | 0.34% | 57.76% | 1.74% | 33 | 65.00% | 9 | - |
| 31 Dec, 18 | 36 | -18.18% | 14,369,930 | -10.66% | 57.61% | 1.24% | 20 | -54.55% | 9 | - |
| 30 Sep, 18 | 44 | - | 16,085,187 | - | 68.02% | - | 44 | - | - | - |
Aquestive Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Aquestive Therapeutics's stock was made by Kraus Carl N on Aug 12 2024, selling 10,819 shares at $3.43 per share (valued at $37.11K).
Aquestive Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | 4 | 200.00% |
| Q1 2024 | 16 | 11 | 145.45% |
| Q3 2023 | 9 | - | - |
| Q2 2023 | 14 | 1 | 1400.00% |
| Q1 2023 | 8 | 6 | 133.33% |
| Q4 2022 | 5 | - | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 18 | - | - |
| Q1 2022 | 13 | - | - |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 8 | 1 | 800.00% |
| Q1 2021 | 15 | 9 | 166.67% |
| Q4 2020 | 1 | 2 | 50.00% |
| Q3 2020 | - | 1 | - |
| Q2 2020 | 10 | 13 | 76.92% |
| Q1 2020 | 15 | 8 | 187.50% |
| Q4 2019 | 4 | 12 | 33.33% |
| Q3 2019 | 18 | 8 | 225.00% |
| Q2 2019 | 11 | 8 | 137.50% |
| Q1 2019 | 12 | 8 | 150.00% |
8 total buy trades, and 4 total sell trades (buy/sell ratio of 2.00%) were made by Aquestive Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 2 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 3 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | - | 5 | - |
| Q1 2020 | 2 | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 13 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Aquestive Therapeutics's stocks.
Aquestive Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| LNTH | Lantheus Holdings, Inc. |
| EVOK | Evoke Pharma, Inc. |
| ANIP | ANI Pharmaceuticals, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| ORGO | Organogenesis Holdings Inc. |
| DVAX | Dynavax Technologies Corporation |
| GHSI | Guardion Health Sciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ALIM | Alimera Sciences, Inc. |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| ACRX | Talphera, Inc. |
| ADMP | Adamis Pharmaceuticals Corporation |
| LSDI | Lucy Scientific Discovery Inc. |
| AGRX | Agile Therapeutics, Inc. |
| ALKS | Alkermes plc |
| EGRX | Eagle Pharmaceuticals, Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |
AQST Ownership FAQ
Who Owns Aquestive Therapeutics?
Aquestive Therapeutics is owned by institutional shareholders (57.59%), insiders (5.03%), and public (37.39%). The largest institutional shareholder of Aquestive Therapeutics is BRATTON CAPITAL MANAGEMENT, L.P. (13.33% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.09% of total shares).
Who are the major institutional shareholders of Aquestive Therapeutics?
Aquestive Therapeutics's major institutional shareholders are BRATTON CAPITAL MANAGEMENT, L.P., VR ADVISER, LLC, BLACKROCK INC., VANGUARD GROUP INC, and FRANKLIN RESOURCES INC. The top five shareholders own together 37.90% of the company's share outstanding.
How many Aquestive Therapeutics shareholders are there?
As of Jun 2024, there are 98 institutional shareholders of Aquestive Therapeutics.
What percentage of Aquestive Therapeutics is owned by BRATTON CAPITAL MANAGEMENT, L.P?
BRATTON CAPITAL MANAGEMENT, L.P owns 9.81M shares of Aquestive Therapeutics, representing 13.33% of the company's total shares outstanding, valued at $25.51M (as of Jun 2024).
What percentage of Aquestive Therapeutics is owned by VR ADVISER, LLC?
As of Jun 2024, VR ADVISER, LLC holds 5.56M shares of Aquestive Therapeutics (AQST), compromising 7.55% of the company, valued at $14.44M.
What percentage of Aquestive Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Aquestive Therapeutics. The company owns 5.45M of the company's shares outstanding (worth $14.18M).